JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MSGN
2151
DELISTED
MSG Networks Inc.
MSGN
| $8.91M | ﹤0.01% |
372,196
+350,651
| +1,628% | +$7.43M |
2015 Q4
10 quarters
|
|
2152
Autohome
ATHM
$2.4B
| $8.88M | ﹤0.01% |
87,936
+73,709
| +518% | +$7.56M |
2017 Q2
4 quarters
|
|
|
EGIO
2153
DELISTED
Edgio, Inc. Common Stock
EGIO
| $8.88M | ﹤0.01% |
49,642
-4,543
| -8% | -$881K |
2016 Q4
6 quarters
|
|
2154
Timken Company
TKR
$8.25B
| $8.87M | ﹤0.01% |
203,684
+51,899
| +34% | +$2.42M |
2013 Q2
20 quarters
|
|
2155
CALL
BioMarin Pharmaceuticals
BMRN
$11.3B
| $8.86M | ﹤0.01% |
94,000
+44,000
| +88% | +$3.85M |
2017 Q4
2 quarters
|
|
|
AKRX
2156
DELISTED
Akorn Inc
AKRX
| $8.86M | ﹤0.01% |
533,728
-2,190,962
| -80% | -$33.6M |
2013 Q2
20 quarters
|
|
2157
CALL
Howmet Aerospace
HWM
$91.1B
| $8.85M | ﹤0.01% |
+678,080
| New | +$10.1M |
2018 Q2
0 quarters
|
|
|
2158
PUT
Howmet Aerospace
HWM
$91.1B
| $8.85M | ﹤0.01% |
+678,080
| New | +$10.1M |
2018 Q2
0 quarters
|
|
2159
Xencor
XNCR
$1.84B
| $8.84M | ﹤0.01% |
238,835
-10,082
| -4% | -$347K |
2013 Q4
18 quarters
|
|
|
EVHC
2160
CALL
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $8.8M | ﹤0.01% |
+200,000
| New | +$8.21M |
2018 Q2
0 quarters
|
|
2161
Bio-Rad Laboratories Class A
BIO
$9.51B
| $8.79M | ﹤0.01% |
30,459
-6,658
| -18% | -$1.84M |
2013 Q2
20 quarters
|
|
2162
Ultrapar
UGP
$7.82B
| $8.79M | ﹤0.01% |
1,484,488
+1,425,056
| +2,398% | +$11M |
2013 Q2
20 quarters
|
|
|
BFS
2163
Saul Centers
BFS
$741M
| $8.76M | ﹤0.01% |
163,444
+67,999
| +71% | +$3.4M |
2013 Q2
20 quarters
|
|
|
MITL
2164
DELISTED
Mitel Networks Corporation
MITL
| $8.76M | ﹤0.01% |
+798,275
| New | +$8.55M |
2018 Q2
0 quarters
|
|
2165
Home BancShares
HOMB
$5.71B
| $8.74M | ﹤0.01% |
387,491
+89,740
| +30% | +$2.08M |
2013 Q2
20 quarters
|
|
2166
Integra LifeSciences
IART
$1.25B
| $8.74M | ﹤0.01% |
135,696
+119,945
| +762% | +$7.43M |
2014 Q4
14 quarters
|
|
2167
Alpha and Omega Semiconductor
AOSL
$874M
| $8.74M | ﹤0.01% |
613,725
-203,363
| -25% | -$3.13M |
2013 Q2
20 quarters
|
|
2168
Casey's General Stores
CASY
$22.9B
| $8.71M | ﹤0.01% |
82,885
-104,989
| -56% | -$10.6M |
2013 Q2
20 quarters
|
|
|
ADAM
2169
Adamas Trust
ADAM
$699M
| $8.7M | ﹤0.01% |
362,038
+43,379
| +14% | +$1.06M |
2015 Q3
11 quarters
|
|
|
FLOW
2170
DELISTED
SPX FLOW, Inc.
FLOW
| $8.7M | ﹤0.01% |
198,712
-134,901
| -40% | -$6.17M |
2015 Q3
11 quarters
|
|
|
BPL
2171
CALL
DELISTED
Buckeye Partners, L.P.
BPL
| $8.67M | ﹤0.01% |
246,700
+100,000
| +68% | +$3.82M |
2018 Q1
1 quarter
|
|
|
DNB
2172
DELISTED
Dun & Bradstreet
DNB
| $8.65M | ﹤0.01% |
70,557
+495
| +0.7% | +$60.2K |
2013 Q2
20 quarters
|
|
|
FFIC
2173
DELISTED
Flushing Financial
FFIC
| $8.62M | ﹤0.01% |
330,354
-18,619
| -5% | -$499K |
2013 Q2
20 quarters
|
|
2174
PUT
Xerox
XRX
$412M
| $8.6M | ﹤0.01% |
358,500
+88,500
| +33% | +$2.5M |
2018 Q1
1 quarter
|
|
2175
iShares Short Maturity Bond ETF
NEAR
$5.1B
| $8.56M | ﹤0.01% |
170,697
+34,532
| +25% | +$1.73M |
2015 Q2
12 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.